FTC sues major pharmacy profit supervisors about insulin price ranges The agency introduced motion from Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the list price of everyday living-preserving insulin medications. Insurers will continue vertically integrating to maintain far more profits in-residence, and https://sethtkaqg.losblogos.com/30027225/5-essential-elements-for-healthcare-news